Maggie Lowenstein
@m_lowenstein
primary care + addiction medicine doc @pennmedicine @CAMP_penn | researching substance use treatment + harm reduction | @NCSP_Penn @ucsfDGIM alum
ID:2838295236
02-10-2014 19:30:14
315 Tweets
961 Followers
1,0K Following
New JAMA we report on a disturbing trend: discharges 'before medically advised' rose dramatically from 2016-2020 for patients with opioid use disorder M. Kit Delgado, MD, MS Maggie Lowenstein Ryan Greysen
Our team and colleagues presenting at ASAM today on Buprenorphine Telehealth Jeanmarie Perrone MD Nicole M O'Donnell Maggie Lowenstein
What can we learn from buprenorphine precipitated withdrawal in the ED/hospital? A 🧵 Austin Kilaru Jeanmarie Perrone MD M. Kit Delgado, MD, MS Maggie Lowenstein Ashish Thakrar, MD, MS JACEP Open NIDAnews Penn Medicine #emergencymedicine #toxtwitter
Check out this amazing work led by Ashish Thakrar, MD, MS to improve care for patients with opioid use disorder in the hospital.
Full text: ascpjournal.biomedcentral.com/articles/10.11…
Collaborative work by a multi-disciplinary team at
Center for Addiction Medicine & Policy including Peggy Compton, Jeanmarie Perrone MD, Maggie Lowenstein, M. Kit Delgado, MD, MS, Jen Olenik, MD, and others with implementation led by the tireless and inspiring pharmacist Tanya Uritsky.
New research out in NEJM Catalyst finds that the telemedicine program CareConnect helps eliminate barriers to treatment for patients with opioid use disorder ( #OUD ) ft. Maggie Lowenstein, Jeanmarie Perrone MD & Nicole M O'Donnell (@CAMP_penn) bit.ly/3Os2N2K
Kudos to Jasmine Barnes and the whole team for this amazing work
catalyst.nejm.org/doi/abs/10.105…
Thx Aubrey Whelan The Philadelphia Inquirer for coverage of our Penn Medicine safety net CareConnect warmline for substance use tx. Grateful for dedicated Center for Addiction Medicine & Policy team Nicole M O'Donnell Maggie Lowenstein Jasmine, Gilly brittany salerno (she/her) inquirer.com/health/suboxon…